Giamaludin, Baby Boy .

HRN: 28-66-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
AMPICILLIN 250MG (VIAL)
03/11/2026
03/18/2026
IVTT
65mg
Q12h
PSNB
Remove - Pending Acceptance
03/11/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
03/11/2026
03/18/2026
IVTT
6mg
Q24h
PSNB
Remove - Pending Acceptance
03/11/2026
CEFOTAXIME 500MG (VIAL)
03/11/2026
03/18/2026
IV
65mg
Q8h
T/C Neonatal Pneumonia; PSNB
Remove - Pending Acceptance
03/12/2026
CEFOTAXIME 500MG (VIAL)
03/12/2026
03/19/2026
SLOW IV DRIP
65mg
Q12
PSNB
Checking Initial Appropriateness 
03/22/2026
CEFTAZIDIME 1GM (VIAL)
03/22/2026
03/29/2026
IV
36mg
Q12
RDS Sec To Prematurity
Remove - Pending Acceptance
03/22/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/22/2026
03/29/2026
IV
14mg
Q36
RDS Sec To Prematurity
Remove - Pending Acceptance
03/22/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/22/2026
03/29/2026
IV
15mg
LOADING DOSE
RDS Sec To Prematurity
Remove - Pending Acceptance
03/22/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/22/2026
03/29/2026
IV
7mg
Q48
RDS Sec To Prematurity
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: